Stryker Corporation SYK

272.36 2.61 0.97% as of 25 Sep
Market cap
$103.9B
P/E
28.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Stryker Corporation (SYK) P/B ratio

As of 25 September 2026, Stryker Corporation (SYK) trades at a P/B ratio of 4.4×. Over the past ten years it has ranged from 3.7× (March 2020) to 7.6× (September 2021); the current reading is higher than 7% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 6.0× (9.88%)
FY2024 6.6× 9.93%
FY2023 6.0× 8.00%
FY2022 5.6× (17.37%)
FY2021 6.8× (3.64%)
FY2020 7.0× 14.71%
FY2019 6.1× 22.64%
FY2018 5.0× (15.52%)
FY2017 5.9× 26.48%
FY2016 4.7× 13.76%

Quarterly

Period P/B ratio Change
Jun 2026 5.0× (8.07%)
Mar 2026 5.5× (8.62%)
Dec 2025 6.0× (7.67%)
Sep 2025 6.5× (9.06%)
42 more quarters

Against its own ten years

Low 3.7× High 7.6×
Ten-year median 6.1×
Current reading's percentile 7

P/B ratio against peers

Company P/B ratio
PHG Koninklijke Philips N.V. compare 1.8×
MDT Medtronic PLC compare 2.2×
BSX Boston Scientific Corporation compare 2.6×
GEHC GE HealthCare Technologies Inc. compare 2.7×
STE STERIS plc compare 2.8×
ABT Abbott Laboratories compare 3.4×
SYK Stryker Corporation 4.4×
EW Edwards Lifesciences Corporation compare 4.6×
DXCM DexCom, Inc. compare 12.6×
Medical Devices industry median 2.5×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on SYK